Review
Version 1
This version is not peer-reviewed
G-Quadruplex targeting ligands: A hope and a new horizon in Cancer Therapeutics
Nilanjan Banerjee
Version 1
: Received: 15 November 2018 / Approved: 16 November 2018 / Online: 16 November 2018 (11:34:24 CET)
How to cite: Banerjee, N.; Panda, S.; Chatterjee, S. G-Quadruplex targeting ligands: A hope and a new horizon in Cancer Therapeutics. Preprints 2018, 2018110409 (doi: 10.20944/preprints201811.0409.v1). Banerjee, N.; Panda, S.; Chatterjee, S. G-Quadruplex targeting ligands: A hope and a new horizon in Cancer Therapeutics. Preprints 2018, 2018110409 (doi: 10.20944/preprints201811.0409.v1).
Abstract
G-quadruplex, a unique secondary structure in nucleic acids found throughout human genome elicited widespread interest in the field of therapeutic research. Being present in key regulatory regions of oncogenes, G-quadruplex structure regulates transcription, translation, splicing, telomere stability etc. Changes in its structure and stability lead to differential expression of oncogenes causing cancer. Thus, targeting G-Quadruplex structures with small molecules/ other biologics has shown elevated research interest. Covering previous reports, in this review we try to enlighten the facts on the structural diversity in G-quadruplex ligands aiming to provide newer insights to design first-in-class drugs for the next generation cancer treatment.
Subject Areas
G quadruplex, Oncogene, ligand, cancer
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.
Leave a public commentSend a private comment to the author(s)